These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17463024)

  • 1. An efficient method for the detection and elimination of systematic error in high-throughput screening.
    Makarenkov V; Zentilli P; Kevorkov D; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2007 Jul; 23(13):1648-57. PubMed ID: 17463024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTS-Corrector: software for the statistical analysis and correction of experimental high-throughput screening data.
    Makarenkov V; Kevorkov D; Zentilli P; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2006 Jun; 22(11):1408-9. PubMed ID: 16595559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical analysis of systematic errors in high-throughput screening.
    Kevorkov D; Makarenkov V
    J Biomol Screen; 2005 Sep; 10(6):557-67. PubMed ID: 16103415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical practice in high-throughput screening data analysis.
    Malo N; Hanley JA; Cerquozzi S; Pelletier J; Nadon R
    Nat Biotechnol; 2006 Feb; 24(2):167-75. PubMed ID: 16465162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using clustering techniques to improve hit selection in high-throughput screening.
    Gagarin A; Makarenkov V; Zentilli P
    J Biomol Screen; 2006 Dec; 11(8):903-14. PubMed ID: 17092911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical and graphical methods for quality control determination of high-throughput screening data.
    Gunter B; Brideau C; Pikounis B; Liaw A
    J Biomol Screen; 2003 Dec; 8(6):624-33. PubMed ID: 14711388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings.
    Wu Z; Liu D; Sui Y
    J Biomol Screen; 2008 Feb; 13(2):159-67. PubMed ID: 18216390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hit discovery and hit-to-lead approaches.
    Keseru GM; Makara GM
    Drug Discov Today; 2006 Aug; 11(15-16):741-8. PubMed ID: 16846802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating real-life high-throughput screening data.
    Gribbon P; Lyons R; Laflin P; Bradley J; Chambers C; Williams BS; Keighley W; Sewing A
    J Biomol Screen; 2005 Mar; 10(2):99-107. PubMed ID: 15799953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust statistical methods for hit selection in RNA interference high-throughput screening experiments.
    Zhang XD; Yang XC; Chung N; Gates A; Stec E; Kunapuli P; Holder DJ; Ferrer M; Espeseth AS
    Pharmacogenomics; 2006 Apr; 7(3):299-309. PubMed ID: 16610941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved statistical methods for hit selection in high-throughput screening.
    Brideau C; Gunter B; Pikounis B; Liaw A
    J Biomol Screen; 2003 Dec; 8(6):634-47. PubMed ID: 14711389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which aspects of HTS are empirically correlated with downstream success?
    Bender A; Bojanic D; Davies JW; Crisman TJ; Mikhailov D; Scheiber J; Jenkins JL; Deng Z; Hill WA; Popov M; Jacoby E; Glick M
    Curr Opin Drug Discov Devel; 2008 May; 11(3):327-37. PubMed ID: 18428086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
    Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
    ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliable high-throughput functional screening with 3-FABS.
    Dalvit C; Ardini E; Fogliatto GP; Mongelli N; Veronesi M
    Drug Discov Today; 2004 Jul; 9(14):595-602. PubMed ID: 15239978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel statistical approach for primary high-throughput screening hit selection.
    Yan SF; Asatryan H; Li J; Zhou Y
    J Chem Inf Model; 2005; 45(6):1784-90. PubMed ID: 16309285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated in vitro-in silico screening strategy for the discovery of antibacterial compounds.
    Nybond S; Ghemtio L; Nawrot DA; Karp M; Xhaard H; Tammela P
    Assay Drug Dev Technol; 2015; 13(1):25-33. PubMed ID: 25710544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for content--the evolution of high throughput.
    Dove A
    Nat Biotechnol; 2003 Aug; 21(8):859-64. PubMed ID: 12894197
    [No Abstract]   [Full Text] [Related]  

  • 20. Statistics and decision making in high-throughput screening.
    Coma I; Herranz J; Martin J
    Methods Mol Biol; 2009; 565():69-106. PubMed ID: 19551358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.